Abstract: An accessory device for covering an electronic device, according to various embodiments of the present invention, comprises: a cover part including a front cover for covering at least a part of the front side of the electronic device, a rear cover for covering at least a part of the rear side of the electronic device, and a side part for connecting the front cover and the rear cover; a first component arranged on the front cover; a second component arranged on the inner side of the rear cover; and a printed circuit board electrically connected to the first component and the second component and arranged from the front cover to the rear cover while traversing the side part, wherein at least part of the printed circuit board can include a flexible structure in the folding region of the cover part, corresponding to the movement of the front cover

Abstract: A crystalline modification of triazolopyrazine derivatives binds to a hepatocyte growth factor (HGF) to activate phosphorylation, thereby significantly inhibiting the activity of c-Met kinase triggering cell proliferation, migration, and formation of new blood vessels. Therefore, the compound of the present application may be effectively used for the treatment or prevention of various hyper proliferative disorders mediated by hyper proliferation activation of cells and excessive angiogenesis.

Abstract: The lighting apparatus according to an embodiment includes: a housing including first and second back covers each having an inside surface in a parabola shape; a recess opened at a lower portion of the first and second back covers; a light-transmissive sheet arranged obliquely in a recess of the first and second back covers; a light emitting module between the recesses of the first and second back covers; a heat dissipation body in which the light emitting module is disposed; and a first reflective sheet for reflecting light on an inside surface of the first and second back covers, wherein the heat dissipation body includes a heat dissipation portion in which the first and second light emitting modules are disposed and a reflecting portion disposed between the heat dissipation portion and a lower end portion of the light-transmissive sheet, and the first reflective sheet has a plurality of reflective surfaces.

Abstract: Disclosed is a battery balancing apparatus and method. The battery balancing apparatus includes a plurality of balancing circuits, each balancing circuit is connected in parallel to a respective battery cell among a plurality of battery cells and the plurality of balancing circuits are connected in series to each other, in one-to-one relationship; and a control unit operably coupled to each balancing circuit. The control unit selects at least one of the plurality of battery cells as a balancing target, based on a SOC of each battery cell, and outputs an enable signal and a balancing message to each balancing circuit connected to each battery cell selected as the balancing target. Each balancing circuit transmits a first wireless signal and a second wireless signal corresponding to the balancing message by using electric energy stored in each battery cell, when the enable signal is received by each balancing circuit.

Abstract: A method of manufacturing a semiconductor device is disclosed. The method includes forming a first insulting layer on a substrate, forming a first conductor pattern in the first insulating layer, forming a second insulating layer on the first insulating layer, and forming a second wiring pattern and a contact via in the second insulating layer, wherein a top surface of the first insulating layer is higher than a top surface of the first conductor pattern.

Abstract: Disclosed are a natural killer (NK) cell expressing an anti-cotinine chimeric antigen receptor (CAR) specifically binding to cotinine, and a cell therapeutic agent containing the NK cell. The CAR-expressing NK cell which specifically binds cotinine, can effectively move to tumor tissue, regardless of the kind of cancer, depending on the binding substance bound to cotinine. Therefore, the natural killer cell can be usefully employed as a gene therapy exhibiting a highly efficient anticancer effect.

Abstract: An embodiment provides a lens comprising: a lens body; and a cavity disposed in the lens body, wherein the outer surface of the lens body comprises a first side surface forming an acute angle with respect to the bottom surface and slopping toward a central axis thereof, an upper surface including a flat area, and an inflection part disposed between the side surface and the upper surface.

Abstract: The present disclosure relates to a compound having the activity of promoting osteoblast differentiation and inhibiting adipocyte differentiation and a preparation method thereof. The novel compound of the present disclosure increases the expression of the gene ALP involved in the differentiation of osteoblasts, regulates expression of the genes PPAR?, aP2 and CD36 involved in the differentiation of adipocytes, increases bone mineral density (BMD) in an ovariectomized osteoporosis animal model and decreases adipocytes in the bone marrow. Therefore, it can be used as an active ingredient of a medication or a health functional food useful for metabolic bone disease or obesity.

Abstract: The present invention provides a reception apparatus for receiving data from a transmission apparatus in one direction, and a transmission apparatus for transmitting data with regards to the reception apparatus in one direction. If the reception apparatus detects an error in the received data, the reception apparatus informs the transmission apparatus about the error in the received data by switching over one or more communication lines forming a connection with the transmission apparatus. If the transmission apparatus detects a switchover of the one or more communication lines, the transmission apparatus re-transmits the data in which the error occurred to the reception apparatus. According to the present invention, the occurrence of data errors in one-direction data communication is easily recognized, and the reliability of the one-direction data communication is improved.

Abstract: An evaluation system of block copolymer patterns includes a supplier, a plurality of analyzers, and a homopolymer interference remover. The supplier provides a sample including a block copolymer and a homopolymer. The analyzers measure a molecular weight of the block copolymer in the sample, measure a preliminary block ratio, the preliminary block ratio corresponding to a total ratio in the sample of each block in the block copolymer, and selectively measure a ratio of the homopolymer in the sample. The homopolymer interference remover subtracts the ratio of the homopolymer from the preliminary block ratio.

Abstract: The present disclosure relates to a rubber composition for a tire tread, the rubber composition comprising 100 parts by weight of a raw material rubber, 10 to 30 parts by weight of a vegetable oil having a weight ratio of linolenic acid to oleic acid of 1:0.5 to 1:1.5, 10 to 20 parts by weight of a terpene-based resin having a softening point of 110 to 130° C., and 75 to 120 parts by weight of a reinforcing filler, and a tire manufactured using the rubber composition for the tire tread. The present disclosure provides a tread rubber composition for four seasons which improves the braking performance on the ice and snow road surface and the abrasion resistant performance and improves the braking performance on the wet road surface at the same time while minimizing a drop in rotational resistance.

Abstract: A novel antibody against VEGFR2 for use in the prevention or treatment of macular degeneration and cancer, which are angiogenesis-related diseases. The antibody of the present invention is an antibody which specifically binds to VEGFR2 which is overexpressed in vascular endothelial cells. The antibody of the present invention has very low homology compared to the CDR sequences of conventional VEGFR2 target antibodies, and thus is unique in its sequence. Since the antibody of the present invention, when treated alone, has the ability to inhibit vascular endothelial cell growth equivalent to that of ramucirumab which is conventionally used, it is very effective to prevent or treat angiogenesis-related diseases.

Abstract: A display device includes: a flexible substrate including a bending area bent in one direction; an insulating layer on the flexible substrate and comprising a plurality of opening patterns spaced apart from each other at the bending area; and a wavy line extending through the plurality of opening patterns.

Abstract: A flexible organic light-emitting diode display and a method of manufacturing the same are disclosed. In one aspect, the display includes a substrate formed of a first material including a metal and an OLED formed over the substrate.

Abstract: Disclosed is an electronic device including a battery, a case covering the battery, a wireless charging coil positioned between the battery and the case; and a communication antenna positioned between the battery and the wireless charging coil, wherein one of the communication antenna and the wireless charging coil is positioned to surround the other one of the communication antenna and the wireless charging coil, and wherein the communication antenna is spaced from the wireless charging coil by a predetermined distance and prevents interference between the communication antenna and the wireless charging coil.

Abstract: A rollable display device includes a roller, a rollable display that is rollable onto the roller in a first direction, and a plurality of thin plates positioned at a rear surface of the rollable display, the thin plates being rollable onto the roller in the first direction along with the rollable display.

Abstract: Provided is a lens according to an embodiment that comprises: a light entrance surface; and a light exit surface facing the light entrance surface, wherein the product of the height rate (HR) of the light entrance surface and the HR of the light exit surface on a section in one direction ranges from 1.45 to 1.

Abstract: A crystalline modification of triazolopyrazine derivatives binds to a hepatocyte growth factor (HGF) to activate phosphorylation, thereby significantly inhibiting the activity of c-Met kinase triggering cell proliferation, migration, and formation of new blood vessels. Therefore, the compound of the present application may be effectively used for the treatment or prevention of various hyper proliferative disorders mediated by hyper proliferation activation of cells and excessive angiogenesis.

Abstract: According to an embodiment, there is provided a lighting apparatus including: a housing that has a first back cover having a parabolic shape and a recess opened below the first back cover; a first light emitting module that has a circuit board and a plurality of light emitting diodes arranged on the circuit board; a heat radiation body that is disposed in one region of the first back cover and has a first heat radiation portion in which the circuit board is disposed and a first reflection portion which extends from the first heat radiation portion along an contour line of an inner sphere surface of the first back cover; a transparent sheet that is disposed in an oblique shape between a high point of the recess of the first back cover and the heat radiation body; a first reflection sheet that is disposed on the heat radiation body and reflects a first side light emitted from the plurality of light emitting diodes to the transparent sheet; and a second reflection sheet that is disposed on an inner surface of th

Abstract: A novel antibody against VEGFR2 for use in the prevention or treatment of macular degeneration and cancer, which are angiogenesis-related diseases. The antibody of the present invention is an antibody which specifically binds to VEGFR2 which is overexpressed in vascular endothelial cells. The antibody of the present invention has very low homology compared to the CDR sequences of conventional VEGFR2 target antibodies, and thus is unique in its sequence. Since the antibody of the present invention, when treated alone, has the ability to inhibit vascular endothelial cell growth equivalent to that of ramucirumab which is conventionally used, it is very effective to prevent or treat angiogenesis-related diseases.